#Gardasil #HPV #adverseevents #healthliteracy #USA #CDC

💁‍♀️Additionally, we have seen an improved five-year survival rate that has increased to 76.8% from 73.9%, driven by the #HPV #Gardasil vaccine.

And adults up to 45!! #Gardasil

Adults, you can also get vaccinated up to age 45! It's a three-shot series, but don't let that stop you please! #Gardasil

#ThisIsTheWay
#CervicalCancer
#VaccinesWork
#Gardasil
#HPV
#PreventiveCare
#PapSmears

There’s a vaccine that prevents most cervical cancers. #FunFacts #PreventionIsBetterThanTheCure #Gardasil

It's not just #Covid vaccines. This sham panel will likely restrict #HepatitisB vax for babies, #HPV / #Gardasil and others.
RFK Jr and his ilk are a menace to our health.
Where are Senators Cassidy and Collins now?

Merck to cut jobs and costs as demand for Gardasil in China remains weak By Michael Erman (Reuters) -Merck & Co on Tuesday announced job and cost cuts it said will save $3 billion a year as it posted lower second-quarter results due to continuing weak demand for its Gardasil vaccine in China. Shares of the drugmaker fell nearly 3% to $81.58 in premarket trading. The company said the cost cuts include $1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions. It also plans to reduce its global real estate footprint and optimize its manufacturing network. Chief Executive Rob Davis said in a press release that the moves "will redirect investment and resources from more mature areas of our business to our burgeoning array of new growth drivers." The company expects to achieve the full $3 billion in annual savings by the end of 2027. Investors have been concerned about where Merck (NSE:PROR) will replace revenue from its blockbuster cancer treatment Keytruda - the world’s best-selling drug, which is set to lose patent protection toward the end of the decade. Gardasil’s problems in China have also been a drag on the company’s results. Merck said it earned $5.4 billion, or $2.13 a share, in the quarter, down from $5.8 billion, or $2.28 a share, a year earlier. Analysts, on average, had forecast earnings of $2.01 a share. Merck’s quarterly R&D costs were lower than expected. Revenue in the quarter was $15.8 billion, down from $16.1 billion a year earlier. Analysts, on average, were expecting revenue of $15.9 billion. Gardasil sales missed already weak Wall Street estimates. The company said it sold $1.1 billion of the vaccine, which prevents cancer caused by the human papillomavirus, down 55% from a year ago. Analysts had been expecting $1.3 billion of Gardasil sales in the quarter. Merck paused shipments of Gardasil to China in January. It said the decline was primarily in China, but lower demand in Japan had hurt sales as well. Sales of Keytruda rose 9% to just under $8 billion in the quarter, topping analyst forecasts of $7.9 billion. The company, which announced a $10 billion takeover of UK-based Verona Pharma (NASDAQ:VRNA) earlier in July, narrowed its full-year revenue forecast to a range of $64.3 billion to $65.3 billion. It had previously forecast revenue of $64.1 billion to $65.6 billion for the year. It now expects to earn $8.87 to $8.97 a share in 2025. Analysts had forecast 2025 earnings to be $8.87. Before you buy stock in MRK, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is MRK one of them?

Click Subscribe #Merck #Gardasil #JobsCut #CostCutting #HealthcareNews

Could the HPV Vaccine Save Your Life? - OncoDaily Could the HPV vaccine save your life? For millions, it already has and for many more, it could.

Could the HPV Vaccine Save Your Life?

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #HPV #HPVVaccine #CervicalCancer #Gardasil

You don’t get placed on a #RFK #ACIP panel if you aren’t willing to amplify #anti-vaccine #disinformation.

I thought the Dad weeping about his child being vaccinated against his wishes with #Gardasil, a #vaccine that prevents genital warts, a common #STD and #cervical #cancer was very propagistic.

How about the most accurate?

He is a #vaccine #injury #lawyer deeply invested in the financial outcome of #Gardasil injury lawsuits he filed against #Merck.

He has no other source of income, and refused to forego income from the lawsuits.

Testified he is $1.2 million in credit card debt.

#Grift

Yes a skeptic has an open mind.

For #RFK the vaccine-injury-lawyer #grift runs far too deep.

His ongoing financial stake in the outcome of #Gardasil lawsuits against #vaccine maker #Merck drives #RFK’s anti-vax fervor.

He has no interest in science. He is setting himself up to profit later.

RFK Jr. closeup

My latest: What To Expect As The New Vaccine Advisory Committee Meets This Week via @forbes #ACIP #CovidVaccines #Measles #Vaccines #flu #Gardasil #HPV
(hint: It's unlikely to be good)

6/14 Kennedy himself has called Gardasil "the most dangerous vaccine ever invented" and falsely claimed it "actually increases the risk of cervical cancer."

He's been instrumental in organizing litigation campaigns against Merck, the vaccine's manufacturer.
#RFKLies #Gardasil

HPV Vaccination Rollout—Safe, Effective, and Powered by Gardasil 4 Dr. BD Platt Medical history has taught us that vaccination has remained one of the most successful stories of the 21st century. It is safe to say that no other medical intervention has revolutionised healthcare and global quality of life as much as safe vaccination. Perhaps only the dawn of antibiotic usage remains a close second. Dreaded viral diseases once rampant and incurable, have many been relegated to the aisles of medical history books through active effective vaccination. If I could rewind perhaps our memories back to the 1980s, Small pox; a dreaded disease that once debilitated human for centuries was eradicated worldwide via human vaccination and community efforts that led to successful eradication. In context with that era of the 1980s closer to home in Namibia; could we ever forget Polio? The success of the vaccination campaigns of the 1980s to 1990s; “Kick Polio Out of Namibia”. The image of the iconic footballer kicking the disease out of the country resonated so powerful. I doubt there was another local campaign image as strong and iconic. The message remained clear and trusted by community; and together we kicked polio out of the country and globally with effective vaccination. The dawn of new technology has brought with it a recent explosion of general medical vaccination information readily available to everyone. This leaves the average person overwhelmed. This technological ease of information is welcomed and readily accepted if the intention remains ultimately to get people accountable for their individual health. The medical information on vaccination requires not only a focused insight but also holds the individual responsible to a deeper knowledge of the information provided. Thus with said information, the recipient is compelled to refrain from uninformed sources; but rather to seek robust evidence based vaccination advice. This requires many at times starting with the basics of immunology. The main prerogative of health care professionals to provide concise up to date data is heavy laden; however remain at the forefront of accurate evidence based information. This is not a new concept and has always remained paramount to the existence of trustworthy healthcare. The format, speed and packaging of scientific based information however has changed and thus turned into a race of action being the antidote to fear. Cervical cancer is a leading cause of cancer-related deaths among women in Namibia and across southern Africa. The Human Papillomavirus (HPV) is responsible for more than 90% of cervical cancer cases, makingprevention through vaccination a top public health priority. This year, Namibia is taking a historic step by introducing the HPV vaccine nationwide. Gardasil 4, also known as the quadrivalent HPV vaccine, is specifically designed to protect against four major HPV types: 6, 11, 16, and 18. Types 16 and 18 are responsible for approximately 70% of all cervical cancer cases, while types 6 and 11 cause the majority of genital warts. Gardasil 4 has been widely used globally and is approved for use in both girls and boys to prevent various HPV-related cancers and disease the Gardasil 4 are central to its ability to stimulate immunity against HPV. The L1 VLP (virus-like particle) antigens specifically. Gardasil 4 contains VLPs made from the L1 major capsid protein of HPV types 6, 11, 16, and 18. These VLPs self-assemble into structures that mimic the outer shell of the actual HPV virus but contain no active viral genetic material, thus cannot cause direct infection. This simply put means they thus do not produce or replicate in host cell and thus increases the vaccine overall safety profile. The immune system recognises these VLPS as foreign upon injection of Gardasil 4. They can be thought of as an imitation of the natural virus’s surface, the immune system mounts an initial strong response, in turn producing high levels of neutralizing antibodies. These are targeted specifically against the L1 proteins of the included various HPV types. The antibodies produced are highly type-specific. They target the exact HPV types present in the Gardasil4 vaccine. HPV infection is a mucosal surface specific infection and thus these antibodies circulate in the blood found at these specific sites. Once vaccinated person is later exposed to HPV, these mucosal surface antibodies can bind to and neutralize the virus. This prevents the established infection. This antibody response induced by the L1 VLPs is a key reason behind long term efficacy of using this vaccine. In summary, Gardasil 4 prevents cervical and other HPV-related cancers by training the immune system to recognise and block infection from the most dangerous HPV types. This in turn stopping the virus before it can cause cellular changes that leads to this cancer.Thus with the above provided we could aim to support the Namibian HPV initiative by encouraging rollout to our youth and ensuring safe protected health and future. Parents and caregivers: Protect your daughters’ health and future. Sign consent forms and support school vaccination days. Teachers and community leaders: Help share accurate information and encourage participation. Together, we can prevent cervical cancer and save lives.

#HPVVaccination #Gardasil #Vaccination #PublicHealth #HealthAwareness

Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Abstract. This study presents national- and state-level prevalence of major modifiable cancer risk factors, human papillomavirus vaccination, and cancer screenings among US adults in the years during ...

While there there has been a reduction in smoking rates and some improved screening for certain cancers, "...up-to-date human papillomavirus vaccination prevalence was flat between 2021 and 2023 (61.4% in ages 13–17 years)."

New findings: aacrjournals.org/cebp/article...

#HPV #Gardasil

Pomerantz Law Firm Alerts Merck Investors on Class Action Lawsuit and Deadlines The Pomerantz Law Firm has filed a class action lawsuit against Merck & Co., Inc. for investors who suffered losses, reminding them of key deadlines.

Pomerantz Law Firm Alerts Merck Investors on Class Action Lawsuit and Deadlines #United_States #New_York #Inc. #Pomerantz #Merck_&_Co. #Gardasil

Class Action Lawsuit Against Merck & Co., Inc. Seeks Shareholder Recovery A class action has been filed against Merck & Co., Inc. seeking recovery for investors due to misleading revenue forecasts. Shareholders are urged to act promptly.

Class Action Lawsuit Against Merck & Co., Inc. Seeks Shareholder Recovery #USA #New_York #Gross_Law_Firm #Inc. #Merck_&_Co. #Gardasil

Class Action Lawsuit Filed Against Merck & Co. – Important Deadline Approaching for Shareholders A class action has been filed against Merck & Co., Inc. Shareholders must act by April 14, 2025, to participate. Key allegations involve Gardasil sales expectations.

Class Action Lawsuit Filed Against Merck & Co. – Important Deadline Approaching for Shareholders #United_States #New_York #Class_Action #Inc. #Merck_&_Co. #Gardasil

Merck & Co., Inc. Faces Class Action Lawsuit Amid Gardasil Sales Decline The Gross Law Firm has alerted investors of Merck & Co., Inc. regarding a class action lawsuit due to significant stock price decline after disappointing sales news.

Merck & Co., Inc. Faces Class Action Lawsuit Amid Gardasil Sales Decline #United_States #New_York #Class_Action #Inc. #Merck_&_Co. #Gardasil

Opportunity for MRK Investors to Join Class Action Against Merck & Co., Inc. Investors affected by Merck's misleading statements regarding Gardasil can join a class action lawsuit. The Schall Law Firm offers support for shareholder rights.

Opportunity for MRK Investors to Join Class Action Against Merck & Co., Inc. #United_States #Inc. #Los_Angeles #Schall_Law_Firm #Merck_&_Co. #Gardasil

Court grants summary judgment in Gardasil litigation The summary judgment in Gardasil litigation ruled in favor of Merck, dismissing claims linking the HPV vaccine to POTS and POI.

Written by @doritreiss.bsky.social — Federal Court grants summary judgment in #Gardasil litigation that tried to show that the HPV #vaccine caused postural orthostatic tachycardia syndrome and primary ovarian insufficiency. The evidence did not support the claims

Court grants summary judgment in Gardasil litigation The summary judgment in Gardasil litigation ruled in favor of Merck, dismissing claims linking the HPV vaccine to POTS and POI.

Written by @doritreiss.bsky.social — Federal Court grants summary judgment in #Gardasil litigation that tried to show that the HPV #vaccine caused POTS and primary ovarian insufficiency. The evidence did not support the claims

Court grants summary judgment in Gardasil litigation The summary judgment in Gardasil litigation ruled in favor of Merck, dismissing claims linking the HPV vaccine to POTS and POI.

Written by @doritreiss.bsky.social — Federal Court grants summary judgment in #Gardasil litigation that tried to show that the HPV #vaccine caused POTS and primary ovarian insufficiency. The evidence did not support the claims www.skepticalraptor.com/skepticalrap...

Login • Instagram Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.

Success: Vaccine Prevention of Cervical Cancer: The Gardasil vaccine has been instrumental in cutting the incidence of cervical pre-cancerous lesions by 80% according to the CDC. #cervical #cancer #precancerous #carcinomainsitu #vaccine #gardasil
www.instagram.com/reel/DHDz1lk...

Merck & Co., Inc. Faces Class Action Lawsuit Claiming Securities Violations Merck & Co., Inc. is under fire for alleged securities violations related to Gardasil sales forecasts. Investors are urged to join the class action.

Merck & Co., Inc. Faces Class Action Lawsuit Claiming Securities Violations #None #Gross_Law_Firm #Inc. #Merck_&_Co. #Gardasil

Merck & Co Investors Given Chance to Lead Securities Fraud Case Following Losses Investors facing losses in Merck & Co can now seize the chance to lead a lawsuit for securities fraud amid unreported business challenges. Act by April 14!

Merck & Co Investors Given Chance to Lead Securities Fraud Case Following Losses #United_States #Los_Angeles #Frank_R._Cruz #Gardasil #Merck_&_Co